Accuray to Host ASTRO Investor Meeting on September 16, 2019
The program will include presentations by Accuray's senior management team and clinical key opinion leaders about the Company's solutions for addressing today's cancer challenges and will also include question and answer sessions. The topics being discussed include: Solutions for Today's Market, the Radixact® System and the advanced Synchrony® Motion Tracking and Correction Technology1, the CyberKnife® System and CyberKnife VOLO™ Optimizer Technology, and U.S. Reimbursement Developments.
Due to the limited space, guests must register to attend
For those not attending the ASTRO meeting, a webcast will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors. A replay of the webcast will also be available on the Company's website following the event.
About
Michael Polyviou |
Beth Kaplan |
Investor Relations, EVC Group |
Public Relations Director, Accuray |
+1 (732) 933-2755 |
+1 (408) 789-4426 |
1 "Synchrony® Motion Tracking and Correction Technology" is synonymous with the development name: "Motion Tracking and Compensation Feature for the Radixact® Treatment Delivery System"
View original content to download multimedia:http://www.prnewswire.com/news-releases/accuray-to-host-astro-investor-meeting-on-september-16-2019-300911222.html
SOURCE